首页> 外文期刊>Bulletin of the Korean Chemical Society >Development and Validation of Primary Method for the Determination of Glucose in Human Serum by Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry and Comparison with Field Methods
【24h】

Development and Validation of Primary Method for the Determination of Glucose in Human Serum by Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry and Comparison with Field Methods

机译:同位素稀释液相色谱串联质谱法测定人血清中葡萄糖的主要方法的建立与验证以及与现场方法的比较

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Glucose is a common medical analyte measuring in human serum or blood samples. The development of a primary method is necessary for the establishment of traceability in measurements. We have developed an isotope dilution liquid chromatography tandem mass spectrometry as a primary method for the measurement of glucose in human serum. Glucose and glucose-~(13)C6 in sample were ionized in ESI negative mode and monitored at mass transfers of m/z 179/89 and 185/92 in MRM, respectively. Glucose was separated on NH2P-50 2D column, and the mobile phase was 20 mM NH4OAC in 30% acetonitrile/70% water. Verification of this method was performed by the comparison with NIST SRMs. Our results agreed well with the SRM values. We have developed two levels of glucose serum certified reference material using this method and distributed them to the clinical laboratories in Korea as samples for proficiency testings. The expended uncertainty was about 1.2% on 95% confidence level. In proficiency testings, the results obtained from the clinical laboratories showed about 3.6% and 3.9% RSD to the certified values. Primary method can provide the traceability to the field laboratories through proficiency testings or certified reference materials.
机译:葡萄糖是在人体血清或血液样本中测量的常见医学分析物。为了建立测量的可追溯性,必须开发一种主要的方法。我们已经开发了一种同位素稀释液相色谱串联质谱法,作为测量人血清中葡萄糖的主要方法。样品中的葡萄糖和葡萄糖〜(13)C6以ESI阴性模式电离,并分别在MRM中以m / z 179/89和185/92的质量转移进行监测。在NH 2 P-50 2D柱上分离葡萄糖,流动相为在30%乙腈/ 70%水中的20 mM NH4OAC。通过与NIST SRM进行比较来验证此方法。我们的结果与SRM值非常吻合。我们已经使用这种方法开发了两种水平的葡萄糖血清认证参考物质,并将它们作为能力测试的样品分发给了韩国的临床实验室。在95%的置信水平上,支出的不确定性约为1.2%。在能力测试中,从临床实验室获得的结果显示相对标准值的RSD约为3.6%和3.9%。主要方法可以通过熟练程度测试或经过认证的参考材料来向现场实验室提供可追溯性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号